Drug intelligence / Profile preview

Jing-Fu-Yau-Yu-Bau

Development stage: Unknown
Lead developer: China Medical University Hospital
Administration: Topical

Overview

Jing-Fu-Yau-Yu-Bau is a traditional Chinese medicine (TCM) medicated bath therapy developed by China Medical University Hospital for the management of mild to moderate plaque-type psoriasis. The therapy's primary active component is the leaf of the paper mulberry (*Broussonetia papyrifera* (L.) Vent.), which is rich in phenolics, terpenes, and flavonoids. These constituents are associated with antibacterial, antifungal, antioxidant, and antineoplastic activities. In the context of TCM, the formulation is intended to clear heat, cool blood, and relieve itching. It is administered topically as a medicated bath and has been evaluated in clinical trials as a complementary therapy to standard topical steroids.

Brand names: Jing-Fu-Yau-Yu-Bau
Other names: paper mulberry leafBroussonetia papyrifera leaf

Beyond the preview

Go deeper on Jing-Fu-Yau-Yu-Bau.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jing-Fu-Yau-Yu-Bau.

Explore the full profile